News
PSYBF
0.0065
NaN%
--
Weekly Report: what happened at PSYBF last week (0422-0426)?
Weekly Report · 1d ago
Weekly Report: what happened at PSYBF last week (0415-0419)?
Weekly Report · 04/22 09:59
Weekly Report: what happened at PSYBF last week (0408-0412)?
Weekly Report · 04/15 09:55
Weekly Report: what happened at PSYBF last week (0401-0405)?
Weekly Report · 04/08 09:57
Weekly Report: what happened at PSYBF last week (0325-0329)?
Weekly Report · 04/01 09:57
Weekly Report: what happened at PSYBF last week (0318-0322)?
Weekly Report · 03/25 09:58
Weekly Report: what happened at PSYBF last week (0311-0315)?
Weekly Report · 03/18 09:57
Weekly Report: what happened at PSYBF last week (0304-0308)?
Weekly Report · 03/11 09:56
Weekly Report: what happened at PSYBF last week (0226-0301)?
Weekly Report · 03/04 09:57
Weekly Report: what happened at PSYBF last week (0219-0223)?
Weekly Report · 02/26 10:03
Weekly Report: what happened at PSYBF last week (0212-0216)?
Weekly Report · 02/19 10:04
Weekly Report: what happened at PSYBF last week (0205-0209)?
Weekly Report · 02/12 09:59
Weekly Report: what happened at PSYBF last week (0129-0202)?
Weekly Report · 02/05 10:03
Weekly Report: what happened at PSYBF last week (0122-0126)?
Weekly Report · 01/29 09:58
Weekly Report: what happened at PSYBF last week (0115-0119)?
Weekly Report · 01/22 10:00
Weekly Report: what happened at PSYBF last week (0108-0112)?
Weekly Report · 01/15 09:58
Weekly Report: what happened at PSYBF last week (0101-0105)?
Weekly Report · 01/08 10:00
Weekly Report: what happened at PSYBF last week (1225-1229)?
Weekly Report · 01/01 09:57
Weekly Report: what happened at PSYBF last week (1218-1222)?
Weekly Report · 12/25/2023 10:03
Weekly Report: what happened at PSYBF last week (1211-1215)?
Weekly Report · 12/18/2023 10:05
More
Webull provides a variety of real-time PSYBF stock news. You can receive the latest news about Psybio Therapeau through multiple platforms. This information may help you make smarter investment decisions.
About PSYBF
Psybio Therapeutics Corp, formerly Leo Acquisitions Corp, is a Canada-based biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The Company is developing a portfolio of psychoactive compounds targeted for the treatment of mental health challenges and other disorders. The Company is engaged in the process of developing new drugs by producing psychoactive molecules from genetically modified bacteria.